Literature DB >> 12101227

E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Harry A Rogoff1, Mary T Pickering, Michelle E Debatis, Stephen Jones, Timothy F Kowalik.   

Abstract

It has been proposed that the E2F1 transcription factor serves as a link between the Rb/E2F proliferation pathway and the p53 apoptosis pathway by inducing the expression of p19ARF, a protein that regulates p53 stability. We find that although p19ARF contributes to p53 accumulation in response to E2F expression, p19ARF is not required for E2F1-mediated apoptosis. E2F1 can signal p53 phosphorylation in the absence of p19ARF, similar to the observed modifications to p53 in response to DNA damage. These modifications are not observed in the absence of p19ARF following expression of E2F2, an E2F family member that does not induce apoptosis in mouse embryo fibroblasts but can induce p19ARF and p53 protein expression. p53 modification is found to be crucial for E2F1-mediated apoptosis, and this apoptosis is compromised when E2F1 is coexpressed with a p53 mutant lacking many N- and C-terminal phosphorylation sites. Additionally, E2F1-mediated apoptosis is abolished in the presence of caffeine, an inhibitor of phosphatidylinositol 3-kinase-related kinases that phosphorylate p53. These findings suggest that p53 phosphorylation is a key step in E2F1-mediated apoptosis and that this modification can occur in the absence of p19ARF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101227      PMCID: PMC133953          DOI: 10.1128/MCB.22.15.5308-5318.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  80 in total

1.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.

Authors:  R Sears; K Ohtani; J R Nevins
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.

Authors:  S N Jones; A T Sands; A R Hancock; H Vogel; L A Donehower; S P Linke; G M Wahl; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.

Authors:  K F Macleod; Y Hu; T Jacks
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  Functional analysis of E2F transcription factor.

Authors:  J R Nevins; J DeGregori; L Jakoi; G Leone
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

6.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

7.  mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts.

Authors:  K M McMasters; R Montes de Oca Luna; J R Peña; G Lozano
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

8.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

10.  E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.

Authors:  S W Hiebert; G Packham; D K Strom; R Haffner; M Oren; G Zambetti; J L Cleveland
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more
  33 in total

1.  Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Authors:  Harry A Rogoff; Mary T Pickering; Fiona M Frame; Michelle E Debatis; Yolanda Sanchez; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 2.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

Review 3.  Opposing roles of E2Fs in cell proliferation and death.

Authors:  Meredith E Crosby; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2004-12-21       Impact factor: 4.742

4.  Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.

Authors:  Valentina Fogal; Jung-Kuang Hsieh; Christophe Royer; Shan Zhong; Xin Lu
Journal:  EMBO J       Date:  2005-07-21       Impact factor: 11.598

5.  Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.

Authors:  M E Crosby; J Jacobberger; D Gupta; R M Macklis; A Almasan
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

7.  Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.

Authors:  Erik S Zimmerman; Junjie Chen; Joshua L Andersen; Orly Ardon; Jason L Dehart; Jana Blackett; Shailesh K Choudhary; David Camerini; Paul Nghiem; Vicente Planelles
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.

Authors:  David Engelmann; Susanne Knoll; Daniel Ewerth; Marc Steder; Anja Stoll; Brigitte M Pützer
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

Review 10.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.